Cofactor Genomics said it has made an agreement with NCI, along with agreements regarding research groups at three other academic and pharma institutions, to demonstrate the clinical utility of the company's immune-profiling assay, Cofactor Paragon.
AbbVie and the International Myeloma Foundation entered into a collaboration to conduct a retrospective chart review study to understand and manage multiple myeloma.
Vanderbilt University and the pharmaceutical company Boehringer Ingelheim expanded their existing collaboration to develop anti-cancer compounds.
Urgent action must be taken to address the dramatic rise of cancer drug prices and to better align prices with value, the President's Cancer Panel urged in a recent report.
The American Association for Cancer Research has launched a collaborative initiative that will perform genomic sequencing of both tumor and normal tissue from 2,020 consented African-American cancer patients, and aggregate it with clinical data from the patients.
Aurora Health Care and University of Texas Health Sciences at Houston have joined the Strata Precision Oncology Network.
Paul Engstrom, the Samuel M.V. Hamilton Chair in Cancer Prevention and special adviser to the president at Fox Chase Cancer Center, will receive the Prevent Cancer Foundation's Laurels Award for Lifetime Achievement in Cancer Prevention.
Margaret Bellerjeau, of the Fox Chase–Temple University Hospital Bone Marrow Transplant Program, received the 2018 Nursing Special Interest Group Lifetime Achievement Award from the American Society for Blood and Marrow Transplantation.
David Ashley was named director of the Preston Robert Tisch Brain Tumor Center at Duke. Ashley follows Darell Bigner, who became director emeritus on Feb. 1.
